Article Details

Merck's COVID-19 breakthrough in the US gives boost to ASX- listed PharmAust - Stockhead

Retrieved on: 2021-10-10 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Merck's COVID-19 breakthrough in the US gives boost to ASX- listed PharmAust - Stockhead. View article details on hiswai:

Excerpt

Similar to remdesivir, molnupiravir is an experimental antiviral drug that aims to treat a range of respiratory viruses, including the virus that causes ...

Article found on: stockhead.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up